36460 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Oct 08
00:12 UTC
|
BLK
BlackRock
|
◎ Target | Benjamin Budish ★★★☆☆ #1054 | Overweight | $1,450.00→ $1,420.00-2.1% |
|
Oct 08
00:12 UTC
|
BE
Bloom Energy
|
◎ Target | Manav Gupta ★★★★☆ #336 | Buy | $325.00→ $350.00+7.7% |
|
Oct 08
00:12 UTC
|
BCE
BCE
|
◎ Target | firm only | Buy | C$43.00→ C$41.00-4.7% |
|
Oct 08
00:12 UTC
|
BBIO
BridgeBio Pharma
|
◎ Target | Eliana Merle ★★★☆☆ #1354 | Overweight | $157.00→ $156.00-0.6% |
|
Oct 08
00:12 UTC
|
BAH
Booz Allen Hamilton
|
◎ Target | Howard Rubel not yet tracked | Hold | $80.00→ $75.00-6.2% |
|
Oct 08
00:12 UTC
|
BAH
Booz Allen Hamilton
|
◎ Target | John Godyn ★★★☆☆ #1674 | Neutral | $82.00→ $77.00-6.1% |
|
Oct 08
00:12 UTC
|
AXS
Axis Capital
|
◎ Target | Yaron Kinar ★★★★★ #188 | Outperform | $118.00→ $116.00-1.7% |
|
Oct 08
00:12 UTC
|
AVTR
Avantor
|
◎ Target | Luke Sergott ★★★★★ #75 | Underweight | $13.00→ $15.00+15.4% |
|
Oct 08
00:12 UTC
|
AVBP
ArriVent BioPharma
|
◎ Target | Jeet Mukherjee ★★★☆☆ #2116 | Buy | $42.00→ $29.00-31.0% |
|
Oct 08
00:12 UTC
|
AVBP
ArriVent BioPharma
|
◎ Target | Michael Schmitz not yet tracked | Buy | $45.00→ $18.00-60.0% |
|
Oct 08
00:12 UTC
|
AVBP
ArriVent BioPharma
|
◎ Target | Soumit Roy not yet tracked | Buy | $45.00→ $22.00-51.1% |
|
Oct 08
00:12 UTC
|
AVBP
ArriVent BioPharma
|
◎ Target | Yigal Nochomovitz ★★☆☆☆ #2796 | Buy | $40.00→ $20.00-50.0% |
|
Oct 08
00:12 UTC
|
ARCB
ArcBest
|
◎ Target | Ariel Rosa ★★★☆☆ #1113 | Buy | $173.00→ $170.00-1.7% |
|
Oct 08
00:12 UTC
|
ARCB
ArcBest
|
◎ Target | Lucas Servera ★★★☆☆ #1077 | Buy | $165.00→ $160.00-3.0% |
|
Oct 08
00:12 UTC
|
APTV
Aptiv
|
◎ Target | Joseph Spak ★★★☆☆ #1902 | Buy | $62.00→ $57.00-8.1% |
|
Oct 08
00:12 UTC
|
APD
Air Products and Chemicals
|
◎ Target | Patrick Cunningham ★★★☆☆ #2025 | Neutral | $330.00→ $312.00-5.5% |
|
Oct 08
00:12 UTC
|
AON
AON
|
◎ Target | Ryan Tunis ★★★★★ #305 | Overweight | $433.00→ $400.00-7.6% |
|
Oct 08
00:12 UTC
|
AON
AON
|
◎ Target | Alex Scott ★★★★☆ #552 | Equal Weight | $382.00→ $317.00-17.0% |
|
Oct 08
00:12 UTC
|
AON
AON
|
◎ Target | Yaron Kinar ★★★★★ #188 | Outperform | $366.00→ $324.00-11.5% |
|
Oct 08
00:12 UTC
|
AN
AutoNation
|
◎ Target | Joseph Spak ★★★☆☆ #1902 | Buy | $248.00→ $213.00-14.1% |
|
Oct 08
00:12 UTC
|
AMGN
Amgen
|
◎ Target | Gregory Renza ★★★☆☆ #1601 | Hold | $362.00→ $380.00+5.0% |
|
Oct 08
00:12 UTC
|
AMGN
Amgen
|
◎ Target | Terence Flynn ★★★★☆ #886 | Equal Weight | $362.00→ $359.00-0.8% |
|
Oct 08
00:12 UTC
|
ALL
Allstate
|
◎ Target | Alex Scott ★★★★☆ #552 | Underweight | $226.00→ $221.00-2.2% |
|
Oct 08
00:12 UTC
|
ALL
Allstate
|
◎ Target | Yaron Kinar ★★★★★ #188 | Outperform | $300.00→ $295.00-1.7% |
|
Oct 08
00:12 UTC
|
ALK
Alaska Air Group
|
◎ Target | Christopher Stathoulopoulos ★★★☆☆ #1903 | Positive | $55.00→ $50.00-9.1% |
|
Oct 08
00:12 UTC
|
ALGT
Allegiant Travel
|
◎ Target | Christopher Stathoulopoulos ★★★☆☆ #1903 | Neutral | $110.00→ $85.00-22.7% |
|
Oct 08
00:12 UTC
|
ALB
Albemarle
|
◎ Target | Alexandra Yates ★★★★★ #299 | Buy | $230.00→ $135.00-41.3% |
|
Oct 08
00:12 UTC
|
AJG
Arthur J. Gallagher & Co.
|
◎ Target | Yaron Kinar ★★★★★ #188 | Outperform | $292.00→ $271.00-7.2% |
|
Oct 08
00:12 UTC
|
AJG
Arthur J. Gallagher & Co.
|
◎ Target | Ryan Tunis ★★★★★ #305 | Neutral | $300.00→ $280.00-6.7% |
|
Oct 08
00:12 UTC
|
AIG
American International Group
|
◎ Target | Yaron Kinar ★★★★★ #188 | Neutral | $85.00→ $83.00-2.4% |
|
Oct 08
00:12 UTC
|
AGIO
Agios Pharmaceuticals
|
◎ Target | Gregory Renza ★★★☆☆ #1601 | Buy | $39.00→ $37.00-5.1% |
|
Oct 08
00:12 UTC
|
AFL
Aflac
|
◎ Target | Yaron Kinar ★★★★★ #188 | Underperform | $116.00→ $107.00-7.8% |
|
Oct 08
00:12 UTC
|
ADNT
Adient
|
◎ Target | Joseph Spak ★★★☆☆ #1902 | Buy | $29.00→ $23.00-20.7% |
|
Oct 08
00:12 UTC
|
ACGL
Arch Capital Group
|
◎ Target | Ryan Tunis ★★★★★ #305 | Neutral | $110.00→ $105.00-4.5% |
|
Oct 08
00:12 UTC
|
ABNB
Airbnb
|
◎ Target | Ken Gawrelski ★★★★☆ #868 | Overweight | $186.00→ $185.00-0.5% |
|
Oct 08
00:12 UTC
|
ABG
Asbury Automotive Group
|
◎ Target | Robert Saltzman not yet tracked | Neutral | $250.00→ $193.00-22.8% |
|
Oct 08
00:12 UTC
|
ABBV
AbbVie
|
◎ Target | Terence Flynn ★★★★☆ #886 | Overweight | $296.00→ $310.00+4.7% |
|
Oct 08
00:12 UTC
|
AAL
American Airlines Group
|
◎ Target | Christopher Stathoulopoulos ★★★☆☆ #1903 | Positive | $20.00→ $15.00-25.0% |
|
Oct 08
00:12 UTC
|
AA
Alcoa
|
◎ Target | Bill Peterson ★★★☆☆ #1220 | Neutral | $52.00→ $50.00-3.8% |
|
Oct 08
00:12 UTC
|
AA
Alcoa
|
◎ Target | Carlos De Alba ★★★☆☆ #2257 | Equal Weight | $53.00→ $50.00-5.7% |
|
Oct 08
00:12 UTC
|
A
Agilent Technologies
|
◎ Target | Luke Sergott ★★★★★ #75 | Overweight | $175.00→ $195.00+11.4% |
|
Oct 07
22:12 UTC
|
ZS
Zscaler
|
◎ Target | Roger Boyd ★★★★★ #34 | Buy | $225.00→ $250.00+11.1% |
|
Oct 07
22:12 UTC
|
VC
Visteon
|
◎ Target | Joseph Spak ★★★☆☆ #1902 | Buy | $130.00→ $107.00-17.7% |
|
Oct 07
22:12 UTC
|
TEL
TE Connectivity
|
◎ Target | Joseph Spak ★★★☆☆ #1902 | Buy | $241.00→ $253.00+5.0% |
|
Oct 07
22:12 UTC
|
ST
Sensata Technologies
|
◎ Target | Joseph Spak ★★★☆☆ #1902 | Buy | $57.00→ $54.00-5.3% |
|
Oct 07
22:12 UTC
|
RPM
RPM International
|
◎ Target | Joshua Spector ★★★☆☆ #2030 | Buy | $142.00→ $128.00-9.9% |
|
Oct 07
22:12 UTC
|
PHIN
PHINIA
|
◎ Target | Joseph Spak ★★★☆☆ #1902 | Neutral | $80.00→ $68.00-15.0% |
|
Oct 07
22:12 UTC
|
MBLY
Mobileye Global
|
◎ Target | Joseph Spak ★★★☆☆ #1902 | Neutral | $9.00→ $7.50-16.7% |
|
Oct 07
22:12 UTC
|
LEA
Lear
|
◎ Target | Joseph Spak ★★★☆☆ #1902 | Neutral | $141.00→ $132.00-6.4% |
|
Oct 07
22:12 UTC
|
GNTX
Gentex
|
◎ Target | Joseph Spak ★★★☆☆ #1902 | Neutral | $25.00→ $24.00-4.0% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.